Dow Down 0.22% Nasdaq Up 0.14%

Novo Nordisk A/S (NVO)

-NYSE
45.33 Down 0.08(0.18%) Aug 22, 4:01PM EDT
Prev Close:45.41
Open:45.52
Bid:45.00 x 100
Ask:46.70 x 100
1y Target Est:49.37
Beta:1.04
Next Earnings Date:N/A
Day's Range:45.05 - 45.52
52wk Range:32.20 - 48.42
Volume:927,581
Avg Vol (3m):897,423
Market Cap:119.17B
P/E (ttm):26.08
EPS (ttm):1.74
Div & Yield:0.61 (1.30%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NVODown 0.18%119.17B
LLYUp 0.47%66.79B
PFEUp 0.35%183.38B
SNYDown 1.97%138.24B

Key Statistics

Forward P/E (1 yr):22.33
P/S (ttm):7.97
Ex-Dividend Date:21-Mar-14

Analysts

Annual EPS Est (Dec-14) :1.82
Quarterly EPS Est (Jun-14) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):2.08

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback